What is the current stock price of EBOS Group Limited?

EBOS Group Limited is currently priced at A$23.77 as of the latest trading session on the ASX in Australia. For more insights, visit EBO.AX on Meyka.

How is EBOS performing financially?

EBOS demonstrates solid financial health with a P/E ratio of 23.32 and a debt-to-equity ratio of 0.59. Despite recent price drops, its revenue growth of 8.21% highlights underlying strength.

What are the technical indicators saying about EBOS?

Technical indicators show a bearish momentum, with the RSI at 34.77 and MACD at -0.31, indicating potential oversold conditions and downward pressures.

Is EBOS a dividend-paying company?

Yes, EBOS offers a dividend yield of 4.35%, reflecting its commitment to providing shareholder value even amidst market fluctuations. Its dividend per share is currently at A$1.18.

What are the growth prospects for EBOS in the healthcare sector?

EBOS is well-positioned for long-term growth with strong fundamentals, an 'A-' rating from analysts, and forecasted potential for price recovery to A$32.76 within the next year.

AU Stocks

EBOS Group Limited (EBO.AX): Navigating Market Volatility with a Strong Growth Trajectory

ByHuzaifa Zahoor December 12, 2025December 12, 2025

EBOS Group Limited (EBO.AX) currently trades at A$23.77, a figure underscoring the pressures from its annual low of A$23.65. As a vital player in the Australian healthcare sector, understanding EBOS’s market dynamics, financial health, and growth prospects is critical for stakeholders evaluating its trajectory.